SPE, LC-MS/MS Method for the Determination of Ethinyl Estradiol from Human Plasma

Significance of the Topic

Ethinyl estradiol is a widely used synthetic estrogen in oral contraceptives and hormone therapies. Its determination at ultra-low concentrations in human plasma is critical for pharmacokinetic, clinical and toxicological studies. A reliable, sensitive and high-throughput analytical method ensures accurate dosing, safety monitoring and compliance with regulatory standards.

Objectives and Study Overview

This study aimed to develop and validate a rapid, sensitive LC-MS/MS method for quantifying ethinyl estradiol in human plasma over the range of 5–200 pg/mL. The workflow combined a three-step sample preparation with solid phase extraction (SPE), dansyl chloride derivatization and post-derivatization cleanup, followed by reversed-phase LC separation and tandem mass spectrometric detection.

Methodology and Instrumentation

• Sample Preparation:
  • Initial SPE extraction using Thermo Scientific SOLA SCX cartridges (condition, wash and elution steps with methanol and water mixtures).
  • Dry-down and derivatization with dansyl chloride in bicarbonate buffer (pH 10.5), incubation at 60 °C for 30 min.
  • Secondary SPE cleanup on SOLA SCX to remove excess reagent and interferences.
• Chromatography:
  • Thermo Scientific Syncronis C18 column (50 × 2.1 mm, 1.7 µm) at 30 °C.
  • Gradient elution with water + 0.1% formic acid (A) and acetonitrile (B), flow rate 0.5 mL/min, injection volume 10 µL.
• Mass Spectrometry:
  • Thermo Scientific TSQ Vantage triple quadrupole with HESI-2 source in positive SRM mode.
  • Transitions: dansyl-ethinyl estradiol m/z 530.2→171.0 (CE 34 V), internal standard m/z 534.2→171.0 (CE 36 V).
  • Optimized source parameters: spray voltage 3500 V, vaporizer 500 °C, capillary 375 °C, gas flows and collision pressure controlled.

Key Results and Discussion

The method demonstrated excellent linearity (r² = 0.997) between 5 and 200 pg/mL. The limit of quantitation was 5 pg/mL, with acceptable precision (≤ 11.6% CV at LLOQ) and accuracy (± 8.9% deviation). Recovery rates ranged from 100.1% to 109.8%, and matrix interference remained below ± 12.4%. Chromatograms showed sharp, symmetrical peaks and consistent retention times (~4.4 min).

Benefits and Practical Applications

The described protocol offers high sensitivity and reproducibility while reducing sample and solvent consumption. The SPE-based cleanup delivers clean extracts, minimizing matrix effects. The method is well suited for high-throughput bioanalytical, clinical and QA/QC laboratories, supporting pharmacokinetic profiling, therapeutic drug monitoring and regulatory submissions.

Future Trends and Applications

Emerging opportunities include automation of SPE and derivatization steps, extension to multiplexed steroid panels, integration with high-resolution mass spectrometry and miniaturized sample handling. Further enhancements may target even lower detection limits and faster throughput for large clinical studies.

Conclusion

A streamlined SPE-LC-MS/MS method employing SOLA SCX cartridges, Syncronis C18 chromatography and TSQ Vantage detection enables reliable quantification of derivatized ethinyl estradiol in human plasma. The assay meets stringent bioanalytical criteria and supports diverse applications in pharmaceutical and clinical research.

References

• U.S. Food and Drug Administration Guidance for Industry: Bioanalytical Method Validation, 2013.